BlackRock’s LianBio American Depositary Shares LIAN Stock Holding History

BlackRock’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,195,716	Closed	-$5.34M	–	5430
2023 Q4	$5.34M	Buy	1,195,716 +580,528	+94%	+$2M	﹤0.01%	3662
2023 Q3	$917K	Sell	615,188 -381,155	-38%	-$726K	﹤0.01%	4273
2023 Q2	$2.27M	Sell	996,343 -26,764	-3%	-$61.5K	﹤0.01%	4005
2023 Q1	$2.01M	Hold	1,023,107	–	–	﹤0.01%	4063
2022 Q4	$1.68M	Hold	1,023,107	–	–	﹤0.01%	4206
2022 Q3	$2.05M	Sell	1,023,107 -8,976	-0.9%	-$21.5K	﹤0.01%	4187
2022 Q2	$2.23M	Buy	+1,032,083	New	+$3.5M	﹤0.01%	4213
2022 Q1	–	Sell	-550,000	Closed	-$3.39M	–	5939
2021 Q4	$3.39M	Buy	+550,000	New	+$6.28M	﹤0.01%	4173

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

BlackRock's LIAN Position: Q1 2024 in Review

BlackRock sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 1,195,716 shares — an estimated $5.34M sold.

BlackRock first reported a position in LIAN in Q4 2021 and held it in 8 quarters. The position peaked at $5.34M in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

BlackRock reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
BlackRock sold 1,195,716 LianBio American Depositary Shares shares in Q1 2024, an estimated $5.34M.
BlackRock first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 8 quarters.
BlackRock's LianBio American Depositary Shares position peaked at $5.34M in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.